Lymphoma, Large B-Cell, Diffuse D016403

Diseases [C] » Neoplasms [C04] » Neoplasms by Histologic Type » Lymphoma » Lymphoma, Non-Hodgkin » Lymphoma, B-Cell » Lymphoma, Large B-Cell, Diffuse

Description

Malignant lymphoma composed of large B lymphoid cells whose nuclear size can exceed normal macrophage nuclei, or more than twice the size of a normal lymphocyte. The pattern is predominantly diffuse. Most of these lymphomas represent the malignant counterpart of B-lymphocytes at midstage in the process of differentiation.   MeSH

Subtype Terms (1)

Plasmablastic Lymphoma
22 drugs (17 approved, 5 experimental)


Phase 3 Indicated Drugs (84)

Phase 2 Indicated Drugs (133)

Phase 1 Indicated Drugs (104)


Organization Involved with Phase 3 Indications (106)

Organization Involved with Phase 2 Indications (275)

Aarhus University

Academic and Community Cancer Research United

AIDS Malignancy Consortium

American Cancer Society, Inc.

Anhui Medical University

Apogee Biotechnology Corporation

Asana BioSciences

Ascenta Therapeutics

Assistance Publique - Hôpitaux de Paris

Astellas

Autolus Limited

BeiGene

Beijing InnoCare Pharma Tech Co., Ltd.

Blood and Marrow Transplant Clinical Trials Network

Bloodwise

Boehringer Ingelheim

Bristol-Myers Squibb

Brown University

Canadian Cancer Trials Group

Cancer Research UK

Case Western Reserve University

Cellectar, Inc

Celleron Therapeutics Ltd.

Centaurus Biopharma Co., Ltd.

Center for International Blood and Marrow Transplant Research

Centre Henri Becquerel

Centre Hospitalier ABBEVILLE

Centre Hospitalier COMPIEGNE

Centre Leon Berard

Centro di Riferimento Oncologico - Aviano

Cephalon

Chang Gung University

Changhua Christian Hospital

China Medical University

Chonbuk National University

Chongqing Medical University

Chongqing Precision Biotech Co., Ltd

CHU Henri Mondor

Chulalongkorn University

CHU UCL Namur

Clinica Universidad de Navarra

Cornell University

CureTech Ltd

Curie Institute

Curis

CytomX Therapeutics

Dong-A University

Duke University

Duran i Reynals Hospital

Dynamic Science S.L.

ECOG-ACRIN Cancer Research Group

Eli Lilly

Emory University

Epizyme, Inc.

Erasmus University Rotterdam

Forty Seven, Inc.

Foshan First People's Hospital

French Innovative Leukemia Organisation

Fundación Hospital Alcorcón

Gateway for Cancer Research

Genta

Genzyme

Gesellschaft fur Medizinische Innovation – Hamatologie und Onkologie mbH

Government of China

Government of Singapore

Government of Taiwan

Groupe Hospitalier Public Sud Oise

Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea

Gruppo Italiano Malattie EMatologiche dell'Adulto

Gruppo Italiano Multiregionale per lo studio dei Linfomi e delle Leucemie

Harvard University

Hebrew University

Hefei University

Henan Medical University

Henan University of Traditional Chinese Medicine

Hoosier Cancer Research Network

Hospital Avicenne

Hospital Center of Périgueux

Hospital Center Saint-Quentin

Hospital Clinico Lozano Blesa

Hospital del SAS de Jerez

Hospital Dr. Jose Molina Orosa

Hospital Duran i Reynals

Hospital Morales Meseguer

Hospital Son Espases

Hospital Universitario Central de Asturias

Hospital Universitari Son Dureta

Hospital Virgen de la Concha

HOVON - Dutch Haemato-Oncology Association

Huizhou People's Central Hospital

Humboldt University

Icahn School of Medicine at Mount Sinai

Idera

ImmunogenX

Immunomedics

ImmunoVaccine Technologies, Inc.

Incyte

Indiana University

Inje University

Institut Bergonié

Institut Gustave Roussy

Instytut Hematologii i Transfuzjologii, 02-776 Warszawa ul. Indiry Gandhi 14

Italian Lymphoma Foundation

Jaen Hospital

Jerez Hospital

Jilin University

Jinlin University

Johannes Gutenburg University

Juno Therapeutics, Inc.

J. W. Goethe University

Kaohsiung Medical University

Kartos Therapeutics, Inc.

Kepler University

Kite Pharma, Inc.

Korea Cancer Center Hospital

Kosin University

Kuur Therapeutics

La Jolla Pharmaceutical Company

León Hospital

LifeBridge Health

Louisiana State University

Loyola University

Ludwig Maximilians University

Lund University

Mackay Medical College

Mahidol University

Mansoura University

McGill University

Medical City Children's Hospital, Dallas

Medical College of Wisconsin

Medical University of Vienna

MedImmune

Medivation

Memgen, LLC

Memorial Sloan-Kettering Cancer Center

Merck

Merck KGaA

MethylGene Inc.

Millennium Pharmaceuticals

Molecular Templates

MolMed S.p.A.

Morales i Meseguer Hospital

Nanjing University

National Cancer Institute, France

National Cheng Kung University

National Institutes of Health (NIH)

National Marrow Donor Program

National Taiwan University

Neumedicines Inc.

New York Medical College

Northwestern University

Ohio State University

Oregon Health and Science University

Ortho Biotech, Inc.

Osaka University

Ospedale S. Giovanni Bellinzona

Pardee Foundation

Pavlov First Saint Petersburg State Medical University

PersonGen BioTherapeutics (Suzhou) Co., Ltd.

Pharmatech

Philogen S.p.A.

Plexxikon

Polish Lymphoma Research Group

Pusan National University

Quebec Clinical Research Organization in Cancer

RedHill Biopharma

Rhode Island Hospital

Royal Marsden Hospital NHS Trust

Rush University

Rutgers University

Sanofi

Sanofi-Synthelabo

SCRI Development Innovations

Segovia Hospital

Seoul National University

Sevion Therapeutics

Shanghai Ming Ju Biotechnology Co., Ltd.

Shanghai YingLi Pharmaceutical Co. Ltd.

Shantou University

Shijiazhuang Pharma Group (CSPC)

Singapore General Hospital

Siriraj Hospital

Son Llatzer Hospital

Sorrento Therapeutics, Inc.

Southampton University Hospital NHS Foundation Trust

Sponsor GmbH

Stanford University

State University of New York, Buffalo

Stony Brook University

Sunesis Pharmaceuticals

Sungkyunkwan University

Swiss Group for Clinical Cancer Research

Szpital Morski im. PCK

Taichung Veterans General Hospital

TCR2 Therapeutics

Technical University of Munich

Tel Aviv University

Telik

Temple University

Territorial Hospital Group (GHT) Rance Emeraude

The Alfred Hospital

The Alvin and Lois Lapidus Cancer Institute

The Christie NHS Foundation Trust

The EMMES Corporation

The Foundation Institute San Raffaele G. Giglio of Cefalù

The Leukemia and Lymphoma Society

Thermo Fisher Scientific

The Wayne D. Kuni and Joan E. Kuni Foundation

Thomas Jefferson University

Universidad Autonoma de Madrid

Universidad Autonoma de Nuevo Leon

Universidad Complutense de Madrid

Universidad de Murcia

University of Arizona

University of Barcelona

University of Bern

University of Birmingham

University of Bologna

University of Bordeaux

University of Caen-Normandie

University of Cagliari

University of California, Los Angeles

University of California, San Diego

University of Cantabria

University of Chicago

University of Colorado, Denver

University of Erlangen-Nuremberg

University of Groningen

University of Hamburg

University of Heidelberg

University of Helsinki

University of Las Palmas de Gran Canaria

University of Leeds

University of London

University of Lyon

University of Manchester

University of Maryland

University of Medicine and Dentistry of New Jersey

University of Miami

University of Michigan

University of Montpellier

University of Munster

University of Nebraska

University of Nice Sophia Antipolis

University of North Carolina at Chapel Hill

University of Nottingham

University of Oxford

University of Paris

University of Pennsylvania

University of Picardie Jules Verne

University of Rochester

University of Roma La Sapienza

University of Salamanca

University of Santiago

University of Southern California

University of South Florida

University of Texas at Houston

University of Texas, San Antonio

University of Toronto

University of Tuebingen

University of Turin

University of Ulm

University of Valencia

University of Wisconsin

University of Zaragoza

Vanderbilt University

Virgen de la Concha Hospital

Vita-Salute University of Milano. Italy

Wayne State University

Xuzhou Medical University

Xynomic Pharmaceuticals, Inc.

Yale University

Yonsei University

Zhejiang DTRM Biopharma

Zhejiang Hisun Pharmaceutical Co. Ltd.

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.